Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg M Lauer

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Journal of Virology|October 9, 2015
Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope ProcessingAndreas Walker, Kathrin Skibbe, Eike Steinmann, et al.
Journal of Hepatology|April 17, 2017
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugsChristine Thöns, Tina Senff, Theresa J Hydes, et al.
JAMA|March 19, 2024
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical TrialTracey G Simon, Robert M Wilechansky, Stefania Stoyanova, et al.
Antiviral Therapy|October 7, 2015
The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular diseaseTracey G Simon, Arthur Y Kim, Luisa M Stamm, et al.
Science (New York, N.Y.)|December 1, 2012
Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infectionMichael A Paley, Daniela C Kroy, Pamela M Odorizzi, et al.
Journal of Virology|August 19, 2007
Viral sequence evolution in acute hepatitis C virus infectionThomas Kuntzen, Joerg Timm, Andrew Berical, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology (Baltimore, Md.)|March 28, 2013
Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infectionShirin Ashraf, Katja Nitschke, Usama M Warshow, et al.
The Journal of Clinical Investigation|February 5, 2008
Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusVictoria Kasprowicz, Scott M Ward, Alison Turner, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Journal of Virology|October 9, 2015
Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope ProcessingAndreas Walker, Kathrin Skibbe, Eike Steinmann, et al.
Journal of Hepatology|April 17, 2017
HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugsChristine Thöns, Tina Senff, Theresa J Hydes, et al.
JAMA|March 19, 2024
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical TrialTracey G Simon, Robert M Wilechansky, Stefania Stoyanova, et al.
Antiviral Therapy|October 7, 2015
The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular diseaseTracey G Simon, Arthur Y Kim, Luisa M Stamm, et al.
Science (New York, N.Y.)|December 1, 2012
Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infectionMichael A Paley, Daniela C Kroy, Pamela M Odorizzi, et al.
Journal of Virology|August 19, 2007
Viral sequence evolution in acute hepatitis C virus infectionThomas Kuntzen, Joerg Timm, Andrew Berical, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Precision-Cut Liver Slices as an <i>ex vivo</i> model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology Communications|October 24, 2024
Precision-cut liver slices as an ex vivo model to evaluate antifibrotic therapies for liver fibrosis and cirrhosisYongtao Wang, Ben Leaker, Guoliang Qiao, et al.
Hepatology (Baltimore, Md.)|March 28, 2013
Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infectionShirin Ashraf, Katja Nitschke, Usama M Warshow, et al.
The Journal of Clinical Investigation|February 5, 2008
Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusVictoria Kasprowicz, Scott M Ward, Alison Turner, et al.
Pageof 11